Pediatric-onset multiple sclerosis (POMS) is characterized by high inflammatory disease activity. Our aim was to describe the treatment sequencing and report the impact highly effective disease-modifying treatment (HET) had on disease activity.
The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series / Immovilli, Paolo; De Mitri, Paola; Bazzurri, Veronica; Vollaro, Stefano; Morelli, Nicola; Biasucci, Giacomo; Magnifico, Fabiola; Marchesi, Elena; Lombardelli, Maria Lara; Gelati, Lorenza; Guidetti, Donata. - In: CHILDREN. - ISSN 2227-9067. - 9:11(2022), p. 1698. [10.3390/children9111698]
The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series
Immovilli, Paolo;Bazzurri, Veronica;Biasucci, Giacomo;Marchesi, Elena;
2022-01-01
Abstract
Pediatric-onset multiple sclerosis (POMS) is characterized by high inflammatory disease activity. Our aim was to describe the treatment sequencing and report the impact highly effective disease-modifying treatment (HET) had on disease activity.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
